Surface engineered PEI-modified liposomes for combination treatment of drug-resistant cancers by co-delivery of siRNA and paclitaxel
Surface-modification of nanoparticles with PEG to confer stealth properties has been considered the most common practice for many years. However, controversial and serious challenges related to PEGylation have been identified, including lack of functionality, hindered cellular interaction, allergic...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/D20292338 |